GENEVA, July 31 -- MVRIX CO.,LTD. filed a patent application (KR2025/018776) for “RECOMBINANT BOTULINUM TOXIN AND PHARMACEUTICAL COMPOSITION CONTAINING SAME”. With publication no. WO/2026/160580, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 9/52
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....